Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, Safety and Pharmacokinetic Study of Single Doses of DFN-15 in Post-Surgical Dental Pain

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Celecoxib (Primary)
Indications Dental pain; Postoperative pain
Focus Therapeutic Use
Sponsors Dr Reddys Laboratories

Most Recent Events

22 Jan 2025 According to a Scilex Holding Company media release, today announced that the U.S. FDA has acknowledged the submission of Supplemental New Drug Application (SNDA) for ELYXYB in acute pain indication.
01 Jan 2022 Primary endpoint (Summed Pain Intensity Difference over the first six hours) has been met as per results published in the Pain
01 Jan 2022 Results published in the Pain

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com